Selvaraj, Divakar <br/><br/>
Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking,   [electronic resource] 

 -  Journal of biomolecular structure & dynamics  Feb 2021 
 - 621-634 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-0254 
<br/><br/><label>Standard No.: </label>10.1080/07391102.2020.1715261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Receptor Antagonists--pharmacology<br/>Furans<br/>Humans<br/>Lignans<br/>Male<br/>Molecular Docking Simulation<br/>Molecular Dynamics Simulation<br/>Prostatic Neoplasms--drug therapy<br/>Prostatic Neoplasms, Castration-Resistant<br/>Receptors, Androgen--genetics